BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iovino C, Mastropasqua R, Lupidi M, Bacherini D, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Carnevali A, D'Aloisio R, Cerquaglia A, Finocchio L, Govetto A, Erba S, Triolo G, Di Zazzo A, Forlini M, Vagge A, Giannaccare G. Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature. Pharmaceutics 2020;12:E703. [PMID: 32722556 DOI: 10.3390/pharmaceutics12080703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Wei D, Xu Y, Zhu Q. Hyaluronic acid in ocular drug delivery. Carbohydrate Polymers 2021;264:118006. [DOI: 10.1016/j.carbpol.2021.118006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Iovino C, Peiretti E, Giannaccare G, Scorcia V, Carnevali A. Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19. Front Pharmacol 2021;12:670468. [PMID: 33912065 DOI: 10.3389/fphar.2021.670468] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Kocamiş Ö, Temel E, Özcan G, Aşikgarip N, Örnek K. Choroidal vascularity index after a single dose of intravitreal dexamethasone implant in patients with refractory diabetic macular edema. Photodiagnosis and Photodynamic Therapy 2022. [DOI: 10.1016/j.pdpdt.2022.102996] [Reference Citation Analysis]
4 Sarkar A, Junnuthula V, Dyawanapelly S. Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD). Int J Mol Sci 2021;22:10594. [PMID: 34638935 DOI: 10.3390/ijms221910594] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]